Nieves Purificacion
Martinez Lago
Complexo Hospitalario Universitario de Santiago
Santiago de Compostela, EspañaPublicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (15)
2022
-
Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial
Thrombosis and haemostasis, Vol. 122, Núm. 10, pp. 1653-1661
-
Efficacy and safety of FOLFIRI/aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after failure of an oxaliplatin-based regimen
PLoS ONE, Vol. 17, Núm. 6 June
-
Efficacy, safety and prognostic factors in patients with refractory metastatic colorectal cancer treated with trifluridine/tipiracil plus bevacizumab in a real-world setting
Scientific Reports, Vol. 12, Núm. 1
-
Impact of risk factors on the efficacy and complications of ultrasound-guided percutaneous liver biopsy of space-occupying lesions
Radiologia, Vol. 64, Núm. 6, pp. 497-505
2021
-
Do clinical trials meet current care needs? Views of digestive oncology specialists in galicia (spain) using the delphi method
Healthcare (Switzerland), Vol. 9, Núm. 6
-
Dynamic perspective of the neutrophil-to-lymphocyte ratio in metastatic gastric cancer
Journal of B.U.ON., Vol. 26, Núm. 5, pp. 2131-2140
-
Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain
BMC Cancer, Vol. 21, Núm. 1
-
Prediction of survival in patients with advanced, refractory colorectal cancer in treatment with trifluridine/tipiracil: real-world vs clinical trial data
Scientific Reports, Vol. 11, Núm. 1
-
Real-life use of ramucirumab in gastric cancer in Spain: The RAMIS study
Future Oncology, Vol. 17, Núm. 14, pp. 1777-1791
2020
-
Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: patterns of use and prognostic nomogram
Clinical and Translational Oncology, Vol. 22, Núm. 3, pp. 351-359
2019
-
Is there any affordable and reliable score in local gastric cancer?
Annals of Oncology, Vol. 30, pp. iv60
2018
-
Differences in outcome according to chemotherapy backbone and maintenance treatment in HER2 positive metastatic gastric cancer (GC) or gastroesophageal junction (GEJ)
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii225
2017
-
Assessment of HER2 status in resected gastric cancer in European population
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 28, pp. iii15
2016
-
HIN-1: a New Epigenetic Biomarker Crucial for Therapy Selection in Glioblastoma Multiforme
Molecular Neurobiology, Vol. 53, Núm. 3, pp. 1802-1807
2015
-
Adjuvant treatment with infusional 5-fluorouracil in high risk adenocarcinoma of the stomach or gastroesophageal junction
Clinical and Translational Oncology, Vol. 17, Núm. 11, pp. 856-861